[PLX] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 64.01%
YoY- -103.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 7,526 6,358 2,889 2,081 4,670 1,769 679 396.39%
PBT -11,437 450 -59,148 -2,624 -7,290 -10,736 -8,526 21.60%
Tax 8 3,045 2,087 -189 268 213 314 -91.32%
NP -11,437 450 -59,148 -2,624 -7,290 -10,853 -8,598 20.93%
Tax Rate - -676.67% - - - - - -
Total Cost 18,963 5,908 62,037 4,705 11,960 12,622 9,277 60.99%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -151.97 7.08 -2,047.35 -126.09 -156.10 -613.51 -1,266.27 -75.63%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -0.86 0.04 -4.75 -0.21 -0.07 -0.11 -0.09 349.68%
EPS Diluted -0.86 -0.60 -4.75 -0.21 -0.07 -0.11 -0.09 349.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.